Cargando…

Huntington's disease: the case for genetic modifiers

For almost three decades, Huntington's disease has been a prototype for the application of genetic strategies to human disease. HD, the Huntington's disease gene, was the first autosomal defect mapped using only DNA markers, a finding in 1983 that helped to spur similar studies in many oth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gusella, James F, MacDonald, Marcy E
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768966/ https://www.ncbi.nlm.nih.gov/pubmed/19725930 http://dx.doi.org/10.1186/gm80

Ejemplares similares

Genetic analysis of the GRIK2 modifier effect in Huntington's disease
por: Zeng, Wenqi, et al.
Publicado: (2006)

Huntington’s Disease Pathogenesis: Two Sequential Components
por: Hong, Eun Pyo, et al.
Publicado: (2021)

Population-specific genetic modification of Huntington's disease in Venezuela
por: Chao, Michael J., et al.
Publicado: (2018)

Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease
por: McAllister, Branduff, et al.
Publicado: (2021)

Huntington’s disease age at motor onset is modified by the tandem hexamer repeat in TCERG1
por: Lobanov, Sergey V., et al.
Publicado: (2022)

Hypomorphic mutation of the mouse Huntington’s disease gene orthologue
por: Murthy, Vidya, et al.
Publicado: (2019)

Haplotype analysis of the 4p16.3 region in Portuguese families with Huntington's disease
por: Ramos, Eliana Marisa, et al.
Publicado: (2015)

MicroRNAs Located in the Hox Gene Clusters Are Implicated in Huntington's Disease Pathogenesis
por: Hoss, Andrew G., et al.
Publicado: (2014)

Chromosome substitution strain assessment of a Huntington’s disease modifier locus
por: Ramos, Eliana Marisa, et al.
Publicado: (2015)

Metabolic disruption identified in the Huntington’s disease transgenic sheep model
por: Handley, Renee. R., et al.
Publicado: (2016)

RNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression
por: Labadorf, Adam, et al.
Publicado: (2015)

Correction: RNA Sequence Analysis of Human Huntington Disease Brain Reveals an Extensive Increase in Inflammatory and Developmental Gene Expression
por: Labadorf, Adam, et al.
Publicado: (2016)

Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregation
por: Wang, Jin, et al.
Publicado: (2005)

miR-10b-5p expression in Huntington’s disease brain relates to age of onset and the extent of striatal involvement
por: Hoss, Andrew G, et al.
Publicado: (2015)

Genetic Risk Underlying Psychiatric and Cognitive Symptoms in Huntington’s Disease
por: Ellis, Natalie, et al.
Publicado: (2020)

SUMO-modifying Huntington’s disease
por: Soares, Ericks S., et al.
Publicado: (2022)

PMS1 as a target for splice modulation to prevent somatic CAG repeat expansion in Huntington’s disease
por: McLean, Zachariah L., et al.
Publicado: (2023)

A Multi-Omic Huntington’s Disease Transgenic Sheep-Model Database for Investigating Disease Pathogenesis
por: Mears, Emily R., et al.
Publicado: (2021)

Inactivation of the Huntington's disease gene (Hdh) impairs anterior streak formation and early patterning of the mouse embryo
por: Woda, Juliana M, et al.
Publicado: (2005)

Promotion of somatic CAG repeat expansion by Fan1 knock-out in Huntington’s disease knock-in mice is blocked by Mlh1 knock-out
por: Loupe, Jacob M, et al.
Publicado: (2020)

Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset
por: Ramos, Eliana Marisa, et al.
Publicado: (2012)

Deficiency of Huntingtin Has Pleiotropic Effects in the Social Amoeba Dictyostelium discoideum
por: Myre, Michael A., et al.
Publicado: (2011)

Unbiased Gene Expression Analysis Implicates the huntingtin Polyglutamine Tract in Extra-mitochondrial Energy Metabolism
por: Lee, Jong-Min, et al.
Publicado: (2007)

Transcriptional regulatory networks underlying gene expression changes in Huntington's disease
por: Ament, Seth A, et al.
Publicado: (2018)

A genetic modifier suggests that endurance exercise exacerbates Huntington's disease
por: Corrochano, Silvia, et al.
Publicado: (2018)

Intellectual enrichment and genetic modifiers of cognition and brain volume in Huntington’s disease
por: Papoutsi, Marina, et al.
Publicado: (2022)

Glycation in Huntington’s Disease: A Possible Modifier and Target for Intervention
por: Brás, Inês Caldeira, et al.
Publicado: (2019)

Translational research in Huntington’s disease: opening up for disease modifying treatment
por: Burgunder, Jean-Marc
Publicado: (2013)

Ubiquitin-modifying enzymes in Huntington’s disease
por: Sap, Karen A., et al.
Publicado: (2023)

Exome sequencing of individuals with Huntington’s disease implicates FAN1 nuclease activity in slowing CAG expansion and disease onset
por: McAllister, Branduff, et al.
Publicado: (2022)

Genome-wide significance for a modifier of age at neurological onset in Huntington's Disease at 6q23-24: the HD MAPS study
por: Li, Jian-Liang, et al.
Publicado: (2006)

Irritability in Huntington’s Disease
por: Karagas, Nicholas E., et al.
Publicado: (2020)

Htt(Q111/+) Huntington’s Disease Knock-in Mice Exhibit Brain Region-Specific Morphological Changes and Synaptic Dysfunction
por: Kovalenko, Marina, et al.
Publicado: (2018)

Use of Genetically Altered Stem Cells for the Treatment of Huntington’s Disease
por: Crane, Andrew T., et al.
Publicado: (2014)

Neurodegenerative processes in Huntington's disease
por: Bano, D, et al.
Publicado: (2011)

Predictive genetic testing in Huntington's disease
por: Muthane, Uday
Publicado: (2011)

Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington’s disease motor onset
por: Ramos, Eliana Marisa, et al.
Publicado: (2013)

Genetic mouse models of Huntington’s disease: focus on electrophysiological mechanisms
por: Cepeda, Carlos, et al.
Publicado: (2010)

Olfactory Dysfunction in Huntington’s Disease
por: Patino, Jorge, et al.
Publicado: (2021)

Therapeutic Strategies in Huntington’s Disease: From Genetic Defect to Gene Therapy
por: Jurcau, Anamaria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b2lbhn78p2ua9c1rggn5rrr3oj